In older adults, antipsychotic drugs are commonly prescribed off-label for a number of disorders outside of their Food and Drug Administration (FDA)-approved indications – schizophrenia and bipolar disorder. In a new study, four of the antipsychotics most commonly prescribed off label for use in patients over 40 were found to lack both safety and effectiveness.
In a new study, researchers at the University of California, San Diego School of Medicine, with colleagues elsewhere, describe markers and a model that quantify how aging occurs at the level of genes and molecules, providing not just a more precise way to determine how old someone is, but also perhaps anticipate or treat ailments and diseases that come with the passage of time.
The structure of the universe and the laws that govern its growth may be more similar than previously thought to the structure and growth of the human brain and other complex networks, such as the Internet or a social network of trust relationships between people, according to a new paper published in the science journal Nature’s Scientific Reports.
For work toward a safer approach to treating cancer, electrical engineering Ph.D. student Inanc Ortac from the University of California, San Diego has won first prize in the graduate student category at the 2012 Collegiate Inventors Competition.
Charles F. von Gunten, MD, PhD, FACP, FAAHPM, provost and vice president of the Institute for Palliative Medicine at San Diego Hospice, a teaching affiliate of the UC San Diego School of Medicine, is this year’s American Cancer Society “Pathfinder in Palliative Care” honoree. The award – which recognizes individuals who have demonstrated innovation and ingenuity in their contributions to the advancement of the field of palliative care – was presented today at the Society’s Nationwide Volunteer and Staff Leadership Summit in Atlanta.
Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow, and with development of new treatments for both cancer and age-related macular degeneration, has been named recipient of The Economist magazine’s 2012 Innovation Award for bioscience.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
